We chose the orthotopic YUMM1.7 melanoma cell line because it is anti-PD-1 resistant and presents genetic alterations seen in a large subset of human melanomas (BrafV600E/+; Pten−/−; Cdkn2−/−)29. This evidence concerns the gene PTEN and melanoma.